Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $4.35 Million - $4.95 Million
5,614 Added 969.6%
6,193 $5.44 Million
Q3 2023

Nov 14, 2023

BUY
$692.45 - $844.37 $400,928 - $488,890
579 New
579 $476,000
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $2.15 Million - $2.71 Million
3,744 Added 1066.67%
4,095 $2.82 Million
Q2 2022

Aug 15, 2022

SELL
$548.35 - $738.84 $1 Million - $1.35 Million
-1,832 Reduced 83.92%
351 $207,000
Q1 2022

May 16, 2022

SELL
$595.12 - $698.43 $489,188 - $574,109
-822 Reduced 27.35%
2,183 $1.53 Million
Q4 2021

Feb 14, 2022

SELL
$543.48 - $670.97 $818,480 - $1.01 Million
-1,506 Reduced 33.39%
3,005 $1.9 Million
Q3 2021

Nov 15, 2021

SELL
$574.03 - $680.96 $323,178 - $383,380
-563 Reduced 11.1%
4,511 $2.73 Million
Q2 2021

Aug 16, 2021

SELL
$472.8 - $558.54 $375,876 - $444,039
-795 Reduced 13.55%
5,074 $2.83 Million
Q1 2021

May 14, 2021

BUY
$446.73 - $548.2 $443,602 - $544,362
993 Added 20.37%
5,869 $2.78 Million
Q4 2020

Feb 16, 2021

BUY
$478.3 - $607.98 $897,290 - $1.14 Million
1,876 Added 62.53%
4,876 $2.36 Million
Q3 2020

Nov 16, 2020

SELL
$544.75 - $658.21 $3.06 Million - $3.7 Million
-5,617 Reduced 65.19%
3,000 $1.68 Million
Q2 2020

Aug 14, 2020

BUY
$493.32 - $643.92 $3.51 Million - $4.58 Million
7,117 Added 474.47%
8,617 $5.37 Million
Q1 2020

May 15, 2020

BUY
$336.18 - $494.43 $504,270 - $741,645
1,500 New
1,500 $732,000
Q4 2019

Feb 14, 2020

SELL
$274.13 - $376.51 $548,260 - $753,020
-2,000 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$273.46 - $318.39 $546,920 - $636,780
2,000 New
2,000 $555,000
Q2 2019

Aug 14, 2019

SELL
$299.6 - $414.82 $749,000 - $1.04 Million
-2,500 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$372.08 - $439.57 $930,200 - $1.1 Million
2,500 New
2,500 $1.03 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.